These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

211 related items for PubMed ID: 12060980

  • 1. Antioxidant treatment of therapy-resistant idiopathic membranous nephropathy with probucol: a pilot study.
    Haas M, Mayer G, Wirnsberger G, Holzer H, Ratschek M, Neyer U, Neuweiler J, Kramar R, Schneider B, Breiteneder-Geleff S, Regele HM, Hörl WH, Kerjaschki D.
    Wien Klin Wochenschr; 2002 Feb 28; 114(4):143-7. PubMed ID: 12060980
    [Abstract] [Full Text] [Related]

  • 2. A pilot study of low-dose fludarabine in membranous nephropathy refractory to therapy.
    Boumpas DT, Tassiulas IO, Fleisher TA, Vaughan E, Piscitelli S, Kim Y, Pucino F, Balow JE, Austin HA.
    Clin Nephrol; 1999 Aug 28; 52(2):67-75. PubMed ID: 10480216
    [Abstract] [Full Text] [Related]

  • 3. A randomized pilot trial comparing methylprednisolone plus a cytotoxic agent versus synthetic adrenocorticotropic hormone in idiopathic membranous nephropathy.
    Ponticelli C, Passerini P, Salvadori M, Manno C, Viola BF, Pasquali S, Mandolfo S, Messa P.
    Am J Kidney Dis; 2006 Feb 28; 47(2):233-40. PubMed ID: 16431252
    [Abstract] [Full Text] [Related]

  • 4. Early initiation of tacrolimus or cyclophosphamide therapy for idiopathic membranous nephropathy with severe proteinuria.
    Li X, Lv R, He Q, Li H, Du X, Lin W, Li Q, He X, Wang S, Chen J.
    J Nephrol; 2008 Feb 28; 21(4):584-91. PubMed ID: 18651550
    [Abstract] [Full Text] [Related]

  • 5. Effect of fish oil on oxidative stress, lipid profile and renal function in IgA nephropathy.
    Parinyasiri U, Ong-Ajyooth L, Parichatikanond P, Ong-Ajyooth S, Liammongkolkul S, Kanyog S.
    J Med Assoc Thai; 2004 Feb 28; 87(2):143-9. PubMed ID: 15061297
    [Abstract] [Full Text] [Related]

  • 6. Short- and long-term efficacy of oral cyclophosphamide and steroids in patients with membranous nephropathy and renal insufficiency. Study Group.
    Branten AJ, Wetzels JF.
    Clin Nephrol; 2001 Jul 28; 56(1):1-9. PubMed ID: 11499653
    [Abstract] [Full Text] [Related]

  • 7. A randomized controlled trial of prednisone in patients with idiopathic membranous nephropathy.
    Cattran DC, Delmore T, Roscoe J, Cole E, Cardella C, Charron R, Ritchie S.
    N Engl J Med; 1989 Jan 26; 320(4):210-5. PubMed ID: 2643046
    [Abstract] [Full Text] [Related]

  • 8. A randomized trial of methylprednisolone and chlorambucil in idiopathic membranous nephropathy.
    Ponticelli C, Zucchelli P, Passerini P, Cagnoli L, Cesana B, Pozzi C, Pasquali S, Imbasciati E, Grassi C, Redaelli B.
    N Engl J Med; 1989 Jan 05; 320(1):8-13. PubMed ID: 2642605
    [Abstract] [Full Text] [Related]

  • 9. Early versus late start of immunosuppressive therapy in idiopathic membranous nephropathy: a randomized controlled trial.
    Hofstra JM, Branten AJ, Wirtz JJ, Noordzij TC, du Buf-Vereijken PW, Wetzels JF.
    Nephrol Dial Transplant; 2010 Jan 05; 25(1):129-36. PubMed ID: 19666912
    [Abstract] [Full Text] [Related]

  • 10. [Treatment of idiopathic membranous nephropathy. Is the anti-CD20 antibody rituximab a reasonable option?].
    Busch M, Gerth J, Ott U, Schip A, Haufe CC, Gröne HJ, Wolf G.
    Med Klin (Munich); 2008 Jul 15; 103(7):519-24. PubMed ID: 18604487
    [Abstract] [Full Text] [Related]

  • 11. Low-dose angiotensin-converting-enzyme inhibitor captopril to reduce proteinuria in adult idiopathic membranous nephropathy: a prospective study of long-term treatment.
    Rostoker G, Ben Maadi A, Remy P, Lang P, Lagrue G, Weil B.
    Nephrol Dial Transplant; 1995 Jul 15; 10(1):25-9. PubMed ID: 7724024
    [Abstract] [Full Text] [Related]

  • 12. Efficacy of a second course of immunosuppressive therapy in patients with membranous nephropathy and persistent or relapsing disease activity.
    du Buf-Vereijken PW, Wetzels JF.
    Nephrol Dial Transplant; 2004 Aug 15; 19(8):2036-43. PubMed ID: 15187191
    [Abstract] [Full Text] [Related]

  • 13. Cyclosporine A in treatment of membranous lupus nephropathy.
    Hu W, Liu Z, Shen S, Li S, Yao X, Chen H, Li L.
    Chin Med J (Engl); 2003 Dec 15; 116(12):1827-30. PubMed ID: 14687467
    [Abstract] [Full Text] [Related]

  • 14. Treatment and long-term follow-up of patients with stage II to III idiopathic membranous nephropathy.
    Polenakovik MH, Grcevska L.
    Am J Kidney Dis; 1999 Nov 15; 34(5):911-7. PubMed ID: 10561149
    [Abstract] [Full Text] [Related]

  • 15. Treatment-related changes in urinary excretion of high and low molecular weight proteins in patients with idiopathic membranous nephropathy and renal insufficiency.
    du Buf-Vereijken PW, Wetzels JF.
    Nephrol Dial Transplant; 2006 Feb 15; 21(2):389-96. PubMed ID: 16234291
    [Abstract] [Full Text] [Related]

  • 16. Immunosuppressive therapy with cyclophosphamide and prednisolone in severe idiopathic membranous nephropathy.
    Kibriya MG, Tishkov I, Nikolov D.
    Nephrol Dial Transplant; 1994 Feb 15; 9(2):138-43. PubMed ID: 8190328
    [Abstract] [Full Text] [Related]

  • 17. Treatment of resistant glomerular diseases with adrenocorticotropic hormone gel: a prospective trial.
    Bomback AS, Canetta PA, Beck LH, Ayalon R, Radhakrishnan J, Appel GB.
    Am J Nephrol; 2012 Feb 15; 36(1):58-67. PubMed ID: 22722778
    [Abstract] [Full Text] [Related]

  • 18. [Antioxidant probucol: effects on free radical lipid peroxidation, blood rheology and course of angina pectoris].
    Zakirova AN, Shamaev AG, Mirionkova NA.
    Ter Arkh; 1998 Feb 15; 70(1):29-32. PubMed ID: 9532648
    [Abstract] [Full Text] [Related]

  • 19. Rituximab for idiopathic membranous nephropathy: who can benefit?
    Ruggenenti P, Chiurchiu C, Abbate M, Perna A, Cravedi P, Bontempelli M, Remuzzi G.
    Clin J Am Soc Nephrol; 2006 Jul 15; 1(4):738-48. PubMed ID: 17699281
    [Abstract] [Full Text] [Related]

  • 20. Prognosis of untreated patients with idiopathic membranous nephropathy.
    Schieppati A, Mosconi L, Perna A, Mecca G, Bertani T, Garattini S, Remuzzi G.
    N Engl J Med; 1993 Jul 08; 329(2):85-9. PubMed ID: 8510707
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.